Investigating the Lowest Threshold of Vascular Benefits from LDL Cholesterol Lowering with a PCSK9 mAb Inhibitor (Alirocumab) in Patients with Stable Cardiovascular Disease (INTENS...

por Cacciottolo, Paul J, Kostapanos, Michalis S, Hernan Sancho, Elena, Pavey, Holly, Kaloyirou, Fotini, Vamvaka, Evangelia, Helmy, Joanna, Hubsch, Annette, McEniery, Carmel M, Wilkinson, Ian B, Cheriyan, Joseph
Publicado 2021

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R): A structu...

por Kulkarni, Spoorthy, Fisk, Marie, Kostapanos, Michalis, Banham-Hall, Edward, Bond, Simon, Hernan-Sancho, Elena, Norton, Sam, Cheriyan, Joseph, Cope, Andrew, Galloway, James, Hall, Frances, Jayne, David, Wilkinson, Ian B.
Publicado 2020

Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects

por Tompson, Debra J., Davies, Carwyn, Scott, Nicola E., Cannons, Edward P., Kostapanos, Michalis, Gross, Annette S., Powell, Marcy, Ino, Hiroko, Shimamura, Ryutaro, Ogura, Hirofumi, Nagakubo, Takashi, Igarashi, Harue, Nakano, Atsushi
Publicado 2020

muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized contr...

por Lu, Ing Ni, Kulkarni, Spoorthy, Fisk, Marie, Kostapanos, Michalis, Banham-Hall, Edward, Kadyan, Sonakshi, Bond, Simon, Norton, Sam, Cope, Andrew, Galloway, James, Hall, Frances, Jayne, David, Wilkinson, Ian B., Cheriyan, Joseph
Publicado 2020

Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-c...

por Zhao, Tian Xiao, Kostapanos, Michalis, Griffiths, Charmaine, Arbon, Emma L, Hubsch, Annette, Kaloyirou, Fotini, Helmy, Joanna, Hoole, Stephen P, Rudd, James H F, Wood, Graham, Burling, Keith, Bond, Simon, Cheriyan, Joseph, Mallat, Ziad
Publicado 2018

Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial

por Hall, Frances C, Cheriyan, Joseph, Cope, Andrew P, Galloway, James, Wilkinson, Ian, Bond, Simon, Norton, Sam, Banham-Hall, Edward, Bayes, Hannah, Kostapanos, Michalis, Nodale, Marianna, Petchey, William G, Sheeran, Thomas, Underwood, Jonathan, Jayne, David R
Publicado 2023

Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren’s syndrome

por Jimenez-Royo, Pilar, Bombardieri, Michele, Ciurtin, Coziana, Kostapanos, Michalis, Tappuni, Anwar R, Jordan, Natasha, Saleem, Azeem, Fuller, Teresa, Port, Kathleen, Pontarini, Elena, Lucchesi, Davide, Janiczek, Robert, Galette, Paul, Searle, Graham, Patel, Neel, Kershaw, Lucy, Gray, Calum, Ratia, Nirav, van Maurik, André, de Groot, Marius, Wisniacki, Nicolas, Bergstrom, Mats, Tarzi, Ruth
Publicado 2020